论文信息 - First-line ribociclib (RIB) + letrozole (LET) in hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-2 biomarker analyses. - 字舞流文

First-line ribociclib (RIB) + letrozole (LET) in hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-2 biomarker analyses.

G. Hortobagyi | L. Hart | C. Arteaga | Y. Yap | S. Paluch-Shimon | G. Sonke | K. Petráková | A. Chan | Wei He | H. Ohnstad | C. Villanueva | A. Nusch | S. Stemmer | N. Marschner | A. Favret | F. Su | M. Miller